• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

质子磁共振波谱和 18F-氟胆碱 PET 对鉴别良恶性乳腺病变的诊断性能。

Diagnostic Performance of Proton Magnetic Resonance Spectroscopy and 18F-Fluorocholine PET to Differentiate Benign From Malignant Breast Lesions.

机构信息

Department of Medical Imaging, National Taiwan University Hospital.

出版信息

Clin Nucl Med. 2021 Nov 1;46(11):896-903. doi: 10.1097/RLU.0000000000003869.

DOI:10.1097/RLU.0000000000003869
PMID:34606485
Abstract

PURPOSE

The aim of this study was to evaluate the diagnostic performance of the proton magnetic resonance spectroscopy (MRS) and 18F-fluorocholine (FCH) PET for suspicious breast findings on conventional imaging (mammography and breast ultrasound).

METHODS

From September 2012 to December 2015, 37 women with 39 breast lesions on conventional imaging were enrolled and underwent proton MRS and FCH PET. The MRS parameters of choline signal-to-noise ratio (SNR), choline integral (I(cho)), and the PET parameters including SUVmax in the prone (SUV1) and supine (SUV2) positions were analyzed. Receiver operating characteristic curves with the area under the curve, sensitivity, and specificity under the optimal cutoff points for the different parameters were determined.

RESULTS

Twenty-three lesions (59%) were malignant, and 16 (41.0%) were benign. The malignant lesions tended to show significantly higher MRS and PET parameters than benign lesions (choline SNR, P = 0.007; I(cho), P = 0.003; SUV1 and SUV2, P < 0.0001). Fair to moderate correlations were noted between the choline SNR and PET parameters (SUV1, Spearman rank correlation coefficient, ρ = 0.477; SUV2, ρ = 0.483), as well as I(cho) and PET parameters (SUV1, ρ = 0.493; SUV2, ρ = 0.549). The SUV2 showed the highest diagnostic performance (area under the curve, 0.918). Using 2.5 as the optimal cutoff point, the SUV2 yields 89.5% sensitivity and 87.5% specificity for differentiating malignant from benign lesions.

CONCLUSION

The MRS parameters were fairly to moderately correlated with FCH PET parameters, and both could differentiate malignant from benign breast lesions with SUV2 showing best diagnostic performance.

摘要

目的

本研究旨在评估质子磁共振波谱(MRS)和 18F-氟胆碱(FCH)PET 对常规成像(乳房 X 线摄影和乳房超声)可疑乳房发现的诊断性能。

方法

2012 年 9 月至 2015 年 12 月,共纳入 37 名女性 39 个常规成像的乳房病变患者,并进行质子 MRS 和 FCH PET 检查。分析 MRS 参数胆碱信号与噪声比(SNR)、胆碱积分(I(cho)),以及 PET 参数,包括俯卧位(SUV1)和仰卧位(SUV2)的 SUVmax。根据不同参数的最佳截断点,确定曲线下面积、敏感性和特异性的接收者操作特征曲线。

结果

23 个病变(59%)为恶性,16 个(41.0%)为良性。恶性病变的 MRS 和 PET 参数明显高于良性病变(胆碱 SNR,P = 0.007;I(cho),P = 0.003;SUV1 和 SUV2,P < 0.0001)。胆碱 SNR 与 PET 参数(SUV1,Spearman 秩相关系数,ρ = 0.477;SUV2,ρ = 0.483)以及 I(cho)与 PET 参数(SUV1,ρ = 0.493;SUV2,ρ = 0.549)之间存在中度至中度相关性。SUV2 显示出最高的诊断性能(曲线下面积,0.918)。使用 2.5 作为最佳截断点,SUV2 对鉴别良恶性病变的敏感性为 89.5%,特异性为 87.5%。

结论

MRS 参数与 FCH PET 参数有中度至中度相关性,两者均能鉴别良恶性乳房病变,SUV2 具有最佳的诊断性能。

相似文献

1
Diagnostic Performance of Proton Magnetic Resonance Spectroscopy and 18F-Fluorocholine PET to Differentiate Benign From Malignant Breast Lesions.质子磁共振波谱和 18F-氟胆碱 PET 对鉴别良恶性乳腺病变的诊断性能。
Clin Nucl Med. 2021 Nov 1;46(11):896-903. doi: 10.1097/RLU.0000000000003869.
2
Using (18)F-FLT PET to distinguish between malignant and benign breast lesions with suspicious findings in mammography and breast ultrasound.使用(18)F-FLT PET区分乳腺钼靶和乳腺超声检查有可疑发现的乳腺良恶性病变。
Ann Nucl Med. 2014 Dec;28(10):941-9. doi: 10.1007/s12149-014-0889-7. Epub 2014 Aug 20.
3
The Clinical Role of Dual-Time-Point (18)F-FDG PET/CT in Differential Diagnosis of the Thyroid Incidentaloma.双时相(18)F-FDG PET/CT在甲状腺偶发瘤鉴别诊断中的临床作用
Nucl Med Mol Imaging. 2014 Jun;48(2):121-9. doi: 10.1007/s13139-013-0247-z. Epub 2013 Dec 6.
4
Automated analysis of the total choline resonance peak in breast proton magnetic resonance spectroscopy.乳腺质子磁共振波谱中总胆碱共振峰的自动分析
NMR Biomed. 2024 Feb;37(2):e5054. doi: 10.1002/nbm.5054. Epub 2023 Oct 4.
5
Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET.利用双期18F-氟胆碱PET对原发性前列腺癌进行定位
J Nucl Med. 2006 Feb;47(2):262-9.
6
Diffusion-Weighted Imaging-guided MR Spectroscopy in Breast Lesions using Readout-Segmented Echo-Planar Imaging.使用读出分段回波平面成像的扩散加权成像引导的乳腺病变磁共振波谱分析
Eur Radiol. 2016 Jun;26(6):1565-74. doi: 10.1007/s00330-015-4000-0. Epub 2015 Sep 19.
7
H-MR spectroscopy of suspicious breast mass lesions at 3T: a clinical experience.3T 下乳腺可疑肿块病变的 H-MR 光谱:临床经验。
Radiol Med. 2017 Mar;122(3):161-170. doi: 10.1007/s11547-016-0713-7. Epub 2016 Dec 15.
8
1H-MRS evaluation of breast lesions by using total choline signal-to-noise ratio as an indicator of malignancy: a meta-analysis.以总胆碱信噪比为恶性肿瘤指标的乳腺病变1H-MRS评估:一项荟萃分析。
Med Oncol. 2015 May;32(5):160. doi: 10.1007/s12032-015-0603-1. Epub 2015 Apr 21.
9
Metabolomics of Breast Cancer Using High-Resolution Magic Angle Spinning Magnetic Resonance Spectroscopy: Correlations with 18F-FDG Positron Emission Tomography-Computed Tomography, Dynamic Contrast-Enhanced and Diffusion-Weighted Imaging MRI.使用高分辨率魔角旋转磁共振波谱的乳腺癌代谢组学:与18F-FDG正电子发射断层扫描-计算机断层扫描、动态对比增强和扩散加权成像MRI的相关性
PLoS One. 2016 Jul 26;11(7):e0159949. doi: 10.1371/journal.pone.0159949. eCollection 2016.
10
Clinical relevance of total choline (tCho) quantification in suspicious lesions on multiparametric breast MRI.多参数乳腺 MRI 可疑病变中总胆碱(tCho)定量的临床相关性。
Eur Radiol. 2020 Jun;30(6):3371-3382. doi: 10.1007/s00330-020-06678-z. Epub 2020 Feb 17.

引用本文的文献

1
Metabolic Imaging as a Tool to Characterize Chemoresistance and Guide Therapy in Triple-Negative Breast Cancer (TNBC).代谢成像作为一种工具,用于表征三阴性乳腺癌(TNBC)的化疗耐药性并指导治疗。
Mol Cancer Res. 2023 Oct 2;21(10):995-1009. doi: 10.1158/1541-7786.MCR-22-1004.
2
Prospective validation of 18F-Fluoroethylcholine as a tracer in PET/MRI for the evaluation of breast lesions and prediction of lymph node status.前瞻性验证 18F-氟乙基胆碱作为 PET/MRI 示踪剂用于评估乳腺病变和预测淋巴结状态。
Radiol Med. 2023 Jun;128(6):689-698. doi: 10.1007/s11547-023-01633-6. Epub 2023 May 23.
3
Breast PET/MRI Hybrid Imaging and Targeted Tracers.
乳腺 PET/MRI 融合成像与靶向示踪剂。
J Magn Reson Imaging. 2023 Feb;57(2):370-386. doi: 10.1002/jmri.28431. Epub 2022 Sep 27.